Myocardial stunning : a role for calcium antagonists during reperfusion ?OPIE, L.Cardiovascular research. 1992, Vol 26, Num 1, pp 20-24, issn 0008-6363Article

EFFECT OF DRUG OR ELECTRICALLY INDUCED TACHYARRHYTHMIAS ON THE RELEASE OF LACTATE DEHYDROGENASE (LDH) IN ISOLATED PERFUSED GUINEA-PIG HEARTS. I: COMPARISON OF THE EFFECTS PRODUCED BY OUABAIN, CALCIUM, EPINEPHRINE AND ACONITINETANZ R; OPIE L.1978; J. PHARMACOL. EXPER. THERAPEUT.; USA; DA. 1978; VOL. 206; NO 2; PP. 320-330; BIBL. 18 REF.Article

Personal viewpoint : New developments in the therapy of diabetic hypertensive disease. The ABCD study adds to strong evidence favoring the prime use of ACE inhibitorsOPIE, L. H.Cardiovascular drugs and therapy. 1998, Vol 12, Num 3, pp 233-238, issn 0920-3206Article

New developments in cardiovascular drugs : Vitamin E and antioxidants: An informal and personal viewpointOPIE, L. H.Cardiovascular drugs and therapy. 1997, Vol 11, Num 6, pp 719-721, issn 0920-3206Article

The ever of expanding spectrum of ischemic left ventricular dysfunctionOPIE, L. H.Cardiovascular drugs and therapy. 1994, Vol 8, pp 297-304, issn 0920-3206, SUP2Article

What is new in myocardial Ischemia ? president's opining remarksOPIE, L. H.Cardiovascular drugs and therapy. 1990, Vol 4, pp 765-766, 2 p., Suppl 4Conference Paper

Calcium channel antagonists. V: Second-generation agentsOPIE, L. H.Cardiovascular drugs and therapy. 1988, Vol 2, Num 2, pp 191-203Article

Adequacy of oxygenation of isolated perfused rat heartOPIE, L. H.Basic research in cardiology. 1984, Vol 79, Num 3, pp 300-306, issn 0300-8428Article

Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors: New among Antidiabetic DrugsOPIE, L. H.Cardiovascular drugs and therapy. 2014, Vol 28, Num 4, pp 331-334, issn 0920-3206, 4 p.Article

Calcium channel blockers for hypertension: Dissecting the evidence for adverse effectsOPIE, L. H.American journal of hypertension. 1997, Vol 10, Num 5, pp 565-577, issn 0895-7061, 1Article

New developments in cardiovascular drugs: Heart failure: An informal and personal viewpointOPIE, L. H.Cardiovascular drugs and therapy. 1997, Vol 11, Num 4, pp 519-520, issn 0920-3206Article

Hypertension 1996 : simplified guidelines for primary care nurses and medical studentsOPIE, L. H.SAMJ. South African medical journal. 1996, Vol 86, Num 4, pp 357-358, issn 0256-9574Article

Cholesterol confusion in primary prevention of coronary artery diseaseOPIE, L. H.Cardiovascular drugs and therapy. 1993, Vol 7, Num 5, pp 779-784, issn 0920-3206Article

Modulation of ischemia by regulation of the ATP-sensitive potassium channelOPIE, L. H.Cardiovascular drugs and therapy. 1993, Vol 7, pp 507-513, issn 0920-3206, SUP3Article

Cardiac metabolism : emergence, decline, and resurgence. IIOPIE, L. H.Cardiovascular research. 1992, Vol 26, Num 9, pp 817-830, issn 0008-6363Article

Should calcium antagonists be used after myocardial infarction ? Ischemia selectivity versus vascular selectivityOPIE, L. H.Cardiovascular drugs and therapy. 1992, Vol 6, Num 1, pp 19-24, issn 0920-3206Conference Paper

Calcium channel antagonist in the management of anginal syndromes : changing concepts in relation to the role of coronary vasospasmOPIE, L. H.Progress in cardiovascular diseases. 1996, Vol 38, Num 4, pp 291-314, issn 0033-0620Article

Calcium antagonists post-infarction : the significance of experimental studies on potentially lethal early ischemic ventricular arrhythmiasOPIE, L. H.Cardiovascular drugs and therapy. 1991, Vol 5, Num 4, pp 671-675, issn 0920-3206, 5 p.Article

Postischemic stunning―the case for calcium as the ultimate culpritOPIE, L. H.Cardiovascular drugs and therapy. 1991, Vol 5, Num 5, pp 895-899, issn 0920-3206Article

Pharmacology of acute effort anginaOPIE, L. H.Cardiovascular drugs and therapy. 1989, Vol 3, pp 257-270, suppl. 1Article

Calcium channel antagonists. III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indicationsOPIE, L. H.Cardiovascular drugs and therapy. 1988, Vol 1, Num 6, pp 625-656Article

Calcium channel antagonists. IV: Side effects and contraindications drug interactions and combinationsOPIE, L. H.Cardiovascular drugs and therapy. 1988, Vol 2, Num 2, pp 177-189Article

Calcium channel antagonists. I: Fundamental properties: mechanisms, classification, sites of actionOPIE, L. H.Cardiovascular drugs and therapy. 1987, Vol 1, Num 4, pp 411-430Article

CYCLIC AMP AND ARRHYTHMIAS REVISITEDOPIE L; MULLER CA; LUBBE WF et al.1978; LANCET; GBR; DA. 1978; NO 8096; PP. 921-923; BIBL. 17 REF.Article

Calcium channel antagonists should be among the first-line drugs in the management of cardiovascular diseaseOPIE, L. H.Cardiovascular drugs and therapy. 1996, Vol 10, Num 4, pp 455-461, issn 0920-3206Article